Yannick Plétan
Chief Tech/Sci/R&D Officer at DEINOVE
Profile
Yannick Plétan is currently the Chief Executive Officer at ULTRace Development Partner.
He also holds current positions as an Independent Director & Chief Medical Officer at Deinove SA, Director at NH TherAguix SAS, and Director at NFL Biosciences SAS.
Dr. Plétan's former positions include being a Member-Global Medical Affairs at F.
Hoffmann-La Roche Ltd.
and a Member-Supervisory Board at Crossject SA. Dr. Plétan was previously the Chief Medical Officer & General Manager at Acticor Biotech SAS.
Dr. Plétan's former jobs also include being a Country Medical Director at Ridoret Distribution SARL and Roche SAS, Director, VP, Head-Medical & Scientific Division at Pfizer SAS (France), Head-Global Immunology R&D at Sanofi, and Chief Medical Officer at Pierre Fabre SA. Dr. Plétan holds a doctorate degree from Université de Paris 5 René Descartes and a graduate degree from Harvard Business School.
Yannick Plétan active positions
Companies | Position | Start |
---|---|---|
DEINOVE | Chief Tech/Sci/R&D Officer | 2017-01-19 |
ACTICOR BIOTECH SAS | Chief Tech/Sci/R&D Officer | 2017-12-19 |
CROSSJECT | Director/Board Member | - |
NH THERAGUIX SAS | Director/Board Member | 2019-02-21 |
NFL BIOSCIENCES | Director/Board Member | 2021-05-18 |
ULTRace Development Partner | Chief Executive Officer | - |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Former positions of Yannick Plétan
Companies | Position | End |
---|---|---|
Roche SAS | Corporate Officer/Principal | 2015-12-31 |
SANOFI | Corporate Officer/Principal | - |
░░░░░░ ░░░░░ ░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - |
░░░░░░ ░░░ ░░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - |
░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Yannick Plétan
Harvard Business School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
ACTICOR BIOTECH SAS | Health Technology |
CROSSJECT | Health Technology |
NFL BIOSCIENCES | Health Technology |
SANOFI | Health Technology |
Private companies | 9 |
---|---|
Deinove SA
Deinove SA BiotechnologyHealth Technology Deinove SA is a biotechnology company, which engages in the development of new-generation anti-infective antibiotics and bioactives. Its portfolio include Phy-N-Resist and HEBELYS. The company was founded by Philippe Pouletty and Miroslav Radman on October 11, 2006 and is headquartered in Grabels, France. | Health Technology |
Université de Paris 5 René Descartes | Consumer Services |
Ridoret Distribution SARL
Ridoret Distribution SARL Wholesale DistributorsDistribution Services Ridoret Distribution SARL provides carpentry services. It specializes in doors and windows. The firm also provides client consulting. The company was founded on November 16, 1982 and is headquartered in La Rochelle, France. | Distribution Services |
Pierre Fabre SA
Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Health Technology |
ULTRace Development Partner | |
NH TherAguix SAS
NH TherAguix SAS Pharmaceuticals: MajorHealth Technology NH TherAguix SAS operates as a biotechnology company. The firm develops a nanodrug against cancer called AGuIX based on nanometric structuring that allows intravenous injection and the combination of the following properties to fight tumors: targeting, imaging, and treating. The company was founded by G?raldine Le Duc, Olivier Tillement and Fran?ois Lux in on December 11, 2015 and is headquartered in Meylan, France. | Health Technology |
Pfizer SAS (France)
Pfizer SAS (France) Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer SAS (France) is a French company that manufactures biopharmaceuticals. The company is based in Paris, France. The company was founded in 2000. Franck Le Breguero has been the CEO of the company since 2016. | Health Technology |
Roche SAS | |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Yannick Plétan